European Archives - Page 483 of 1443 - European Medical Journal

Novel Strategy Targets Lymphoma with Cancer-Specific Cell Death Inducers

The new strategy converts CDKs into targeted activators of cancer-specific genes that promote cell death…

Study Identifies Promising Treatment for Diabetes-Induced Heart Disease

A molecule known as LXA4 could serve as a potential treatment for heart disease caused by diabetes.

Adult-Onset Egg White Allergy: Quality of Life Effects

In a small Swiss study, patients with adult-onset egg white allergy exhibited moderate to severe restrictions in daily life.

Clinical Trial Validates New MASLD Drug Therapy

This study examined the efficacy and safety of pemafibrate in 360 patients with MASLD and hypertriglyceridaemia.

Ed Smith

Onc Now: Episode 6: Revolutionising Paediatric Radiation Oncology – Part 1

Join Ed Smith, Professor at the University of Manchester, UK, to discuss the revolutionary potential of proton beam therapy and radiation oncology.

3D-Printed Hydrogel Contact Lens to Transform Ocular Drug Delivery

Discover the future of eye care: 3D-printed contact lenses delivering medication directly and effectively using innovative hydrogels.

Mobile Apps Helpful in Rheumatoid Arthritis Self-Care and Symptom Management

Discover how a mobile app empowers rheumatoid arthritis patients to self-manage symptoms, providing valuable insights without increasing psychological burden.

The word spotlight on a blue background

Spotlight: November 2024

Catch up on all the biggest pharma news to hit the industry last month, with stories spanning the US election, new breakthroughs and more.

Chronic Endometritis Worsens Pregnancy Risks for Women with Endometriosis

Patients with endometriosis and chronic endometritis face higher pregnancy risks despite improved fertility, highlighting the need for careful management.

Lung Cancer Screening Benefits Limited for Smokers with Severe Airflow Limitation

The study followed 18,463 high-risk smokers, who underwent pre-bronchodilator spirometry tests and were tracked over a median period of 6.1 years.